ワクチンの世界市場:小児用ワクチン、成人用ワクチン...市場調査レポートについてご紹介

【英文タイトル】World Vaccines Industry and Market 2015-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 Why You Should Read This Report
1.2 How This Report Delivers
1.3 Main Questions Answered by this Analysis
1.4 Who is this Study for?
1.5 Methods of Research and Analysis
1.6 Frequently Asked Questions (FAQs)
1.7 Some Associated Reports
1.8 About Visiongain

2. Introduction to the World Human Vaccines Market
2.1 Human World Vaccines – Aiming for Global Disease Prevention
2.2 Vaccine Technology
2.2.1 Inactivated Vaccines
2.2.2 Live Attenuated Vaccines
2.2.3 Conjugate Vaccines
2.2.4 Recombinant Vector Vaccines
2.3 Human World Vaccines – Market Segmentation
2.4 Paediatric Vaccines
2.5 Adolescent Vaccines
2.6 Adult Vaccines
2.7 Elderly Vaccines
2.8 Blurred Lines

3. World Vaccine Market Outlook, 2015-2025
3.1 World Vaccine Market, 2014
3.2 World Vaccine Market Forecast: 2015-2025
3.3 World Vaccine Market: Industry Trends, 2015-2025
3.3.1 Demand-Side Trends
3.3.2 Supply-Side Trends
3.3.3 Funding Trends
3.3.4 Decreasing Number of Lower Income Countries (LICs)

4. World Vaccine Submarkets: Prospects, 2015-2025
4.1 Paediatric Vaccines
4.1.1 Paediatric Vaccine Forecast: 2015-2025
4.1.2 Paediatric Vaccine Trends
4.1.2.1 Novel Delivery
4.1.2.2 Fear Factor
4.1.2.3 Novel Vectors
4.1.3 Paediatric Vaccine R&D Pipeline
4.2 Adult Vaccines
4.2.1 Adult Vaccine Forecast: 2015-2025
4.2.2 Adult Vaccine Trends
4.2.2.1 Treat the Untreatable
4.2.2.2 ‘Tis the Season
4.2.2.3 Exotic Killers
4.2.3 Adult Vaccine R&D Pipeline

5. Leading Vaccines: Revenue Predictions to 2025
5.1 Prevnar-13 – Pfizer: Sales Forecasting and Discussions, 2014-2025
5.2 Gardasil – Merck: Sales Forecasting and Discussions, 2014-2025
5.3 PENTAct-HIB – Sanofi: Sales Forecasting and Discussions, 2014-2025
5.4 Pediarix – GSK: Sales Forecasting and Discussions, 2014-2025
5.5 Varivax/M-M-R II/ProQuad – Merck: Sales Forecasting and Discussions, 2014-2025
5.6 Fluzone/Vaxigrip – Sanofi: Sales Forecasting and Discussions, 2014-2025
5.7 Hepatitis Vaccine Franchise – GSK: Sales Forecasting and Discussions, 2014-2025
5.8 Zostavax – Merck: Sales Forecasting and Discussions, 2014-2025
5.9 Pneumovax 23–Merck: Sales Forecasting and Discussions, 2014-2025
5.10 RotaTeq – Merck: Sales Forecasting and Discussions, 2014-2025

6. Leading National Vaccines Markets: 2015-2025
6.1 Human Vaccines: Leading Markets, 2013, 2019 and 2025
6.2 The US Vaccine Market: 2015-2025
6.2.1 The US Vaccine Market: 2014
6.2.2 The US Vaccine Market Forecast: 2015-2025
6.2.3 Obama Healthcare Reform – Benefits for Vaccine Sales
6.3 The Japanese Vaccine Market: 2015-2025
6.3.1 The Japanese Vaccine Market: 2014
6.3.2 The Japanese Vaccine Market Forecast: 2015-2025
6.3.3 Breaking Barriers
6.4 European Union (EU) Vaccine Market: 2015-2025
6.4.1 EU Vaccine Market: 2014
6.4.2 EU Vaccines Market Forecast: 2015-2025
6.4.3 Europe’s Crises
6.5 The German Vaccine Market: 2015-2025
6.5.1 The German Vaccine Market: 2014
6.5.2 The German Vaccine Market Forecast: 2015-2025
6.5.3 Pricey Business
6.6 The French Vaccine Market: 2015-2025
6.6.1 The French Vaccine Market: 2014
6.6.2 The French Vaccine Market Forecast: 2015-2025
6.6.3 French Healthcare System – Events, Policies and Effects
6.7 The UK Vaccine Market: 2015-2025
6.7.1 The UK Vaccine Market: 2014
6.7.2 The UK Vaccine Market: 2015-2025
6.8 The Italian Vaccine Market: 2015-2025
6.8.1 The Italian Vaccine Market: 2014
6.8.2 The Italian Vaccine Market Forecast: 2015-2025
6.8.3 Crumbling Foundation – Challenges in Public Healthcare
6.9 The Spanish Vaccine Market: 2015-2025
6.9.1 The Spanish Vaccine Market: 2014
6.9.2 The Spanish Vaccine Market Forecast: 2015-2025
6.9.3 District Rules – Economic Challenges
6.10 The Brazilian Vaccine Market: 2015-2025
6.10.1 The Brazilian Vaccine Market: 2014
6.10.2 The Brazilian Vaccine Market Forecast: 2015-2025
6.10.3 Dengue Focus
6.11 The Russian Vaccine Market: 2015-2025
6.11.1 The Russian Market: 2014
6.11.2 The Russian Vaccine Market Forecast: 2015-2025
6.11.3 Power of the State
6.12 The Indian Vaccine Market: 2015-2025
6.12.1 The Indian Vaccine Market: 2014
6.12.2 The Indian Vaccine Market Forecast: 2015-2025
6.12.3 Slow Adoption of Vaccines – How Much Progress Possible?
6.13 The Chinese Vaccine Market: 2015-2025
6.13.1 The Chinese Vaccine Market: 2014
6.13.2 The Chinese Vaccine Market Forecast: 2015-2025
6.13.3 Domestic Vaccine Producers and High National Demand

7. Leading Manufacturers of Vaccines for Human Use
7.1 GlaxoSmithKline (GSK)
7.1.1 GSK Vaccine Performance
7.1.2 GSK Developments
7.1.2.1 Mergers and Acquisitions
7.1.2.2 GSK Vaccine Pipeline
7.2 Merck & Co.
7.2.1 Merck Vaccine Performance
7.2.2 Merck Developments
7.2.2.1 Merck Market Movements
7.2.2.2 Collaborations
7.2.2.3 Merck Pipeline
7.3 Sanofi
7.3.1 Sanofi Vaccine Performance
7.3.2 Sanofi Developments
7.3.2.1 Mergers & Acquisitions
7.3.2.2 Sanofi Vaccine Pipeline
7.4 Pfizer
7.4.1 Pfizer Vaccine Performance
7.4.2 Pfizer Developments
7.4.2.1 Pfizer Mergers & Acquisitions
7.4.2.2 Pfizer Pipeline
7.5 Johnson & Johnson
7.6 AstraZeneca
7.7 Other Contenders

8. Qualitative Analysis of the World Vaccines Industry and Market: 2015
8.1 SWOT Analysis of the World Vaccines Industry and Market: 2015-2025
8.1.1 Strengths
8.1.1.1 Ageing Population
8.1.1.2 Strong Research and Development Pipeline
8.1.1.3 Viral Disease Prevention is Crucial
8.1.1.4 Continuing Product Development
8.1.2 Weaknesses
8.1.2.1 R&D Costs
8.1.2.2 Barriers to Market Entry
8.1.3 Opportunities
8.1.3.1 Technological Advances to Protect People from Diseases
8.1.3.2 Vaccine Delivery – Innovations and Opportunities for Improvements
8.1.3.3 Adult Vaccines – High Need
8.1.4 Threats
8.1.4.1 Regulatory Scrutiny Daunting for Some Developers and Marketers
8.1.4.2 Productivity Gap
8.2 STEP Analysis of the World Vaccines Industry and Market: 2015
8.2.1 Social Factors
8.2.1.1 Healthcare Benefits from those Products
8.2.1.2 Public Fears – Resistance from Some Quarters
8.2.2 Technological Forces
8.2.2.1 Technological Improvements to Sustain that Industry’s Success
8.2.3 Economic Factors
8.2.3.1 Costs of Research and Development and Need for Large Vaccine Markets
8.2.3.2 Rising Demand from Less Economically Developed Countries
8.2.4 Political Forces
8.2.4.1 Governmental Influence Shaping the Vaccines Market

9. Opinions from Our Industry Survey
9.1 Progress Statement from GlaxoSmithKline, January 2015
9.1.1 GSK Ebola Vaccine Candidate – Results and Plans
9.2 Interview with Dr Louis J. Picker, Oregon Health and Science University
9.2.1 Challenges of DNA/Ad Vector Vaccines
9.2.2 Broadly Neutralising Antibodies for HIV
9.2.3 A Third Way? The T-Cell Vaccine Approach
9.2.4 Combinations and Other Strategies for HIV
9.2.5 Getting to the Clinic with Therapeutic and Prophylactic HIV Vaccines
9.3 Interview with Tamar Ben-Yedidia, PhD, Chief Scientific Officer, and Tanya Gottlieb, PhD, Business Development, BiondVax Pharmaceuticals
9.3.1 Progress of BiondVax’s Candidate Vaccine
9.3.2 Trialling the Vaccine as a Primer
9.3.3 Assays for Universal Vaccine Effectiveness
9.3.4 Key Differentiators for BiondVax’s Candidate

10. Conclusions
10.1 Serving Needs in Chronic Diseases – Vital Protective Agents
10.2 The Rise of Japan as a Vaccines Market
10.3 The US to Lose its Dominance in Vaccine Sales?
10.4 Emerging National Markets to Increase in Commercial Prominence
10.5 Strong, Promising Research and Development
10.6 Concluding Remarks


【レポート販売概要】

■ タイトル:ワクチンの世界市場:小児用ワクチン、成人用ワクチン
■ 英文:World Vaccines Industry and Market 2015-2025
■ 発行日:2015年2月
■ 調査会社:visiongain
■ 商品コード:VGAIN5020410
■ 調査対象地域:世界
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。